WHO Digital Documentation of COVID-19 Certificates (DDCC)
1.0.1 - release International flag

This page is part of the WHO Digital Documentation of COVID-19 Certificates (DDCC) (v1.0.1: releases Draft) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

ValueSet: Lab Test - Type - COVID-19 - LOINC (Experimental)

Official URL: http://smart.who.int/ddcc/ValueSet/LabTestTypeCovid19LoincValueSet Version: 1.0.1
Active as of 2024-12-18 Computable Name: LabTestTypeCovid19LoincValueSet

This is a one-time snapshot of the allowed values for COVID-19 specific lab tests in EUDCC, retrieved in February 2023 from https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv%3AOJ.L_.2021.230.01.0032.01.ENG. Contents may need to be updated and readers should consult the credential's documentation.

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

Generated Narrative: ValueSet LabTestTypeCovid19LoincValueSet

  • Include these codes as defined in http://loinc.org
    CodeDisplay
    100861-4Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
    100858-0Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
    100862-2Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
    100859-8Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
    100863-0Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
    100860-6Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
    96766-1GISAID sequence accession number
    95942-9Influenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay
    97099-6Influenza virus A and B and SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay
    95941-1Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory specimen by NAA with probe detection
    95380-2Influenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection
    95423-0Influenza virus A and B and SARS-CoV-2 (COVID-19) identified in Respiratory specimen by NAA with probe detection
    95422-2Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Respiratory specimen by NAA with probe detection
    100345-8Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection
    98733-9Percent neutralization by SARS coronavirus 2 spike protein RBD neutralizing antibody in Serum or Plasma by Immunoassay
    99771-8SARS coronavirus 2 spike and nucleocapsid protein stimulated gamma interferon panel - Blood
    98846-9SARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells [Units/volume] corrected for background in Blood by Immunoassay
    98847-7SARS coronavirus 2 stimulated gamma interferon release by lymphocytes [Units/volume] corrected for background in Blood by Immunoassay
    99774-2SARS coronavirus 2 stimulated gamma interferon release by T-cells.Nucleocapsid Ag spot count [#] corrected for background in Blood
    99773-4SARS coronavirus 2 stimulated gamma interferon release by T-cells.Spike Ag spot count [#] corrected for background in Blood
    95209-3SARS-CoV+SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory specimen by Rapid immunoassay
    94763-0SARS-CoV-2 (COVID-19) [Presence] in Specimen by Organism specific culture
    94661-6SARS-CoV-2 (COVID-19) Ab [Interpretation] in Serum or Plasma
    95825-6SARS-CoV-2 (COVID-19) Ab [Presence] in DBS by Immunoassay
    98069-8SARS-CoV-2 (COVID-19) Ab [Presence] in Saliva (oral fluid) by Rapid immunoassay
    94762-2SARS-CoV-2 (COVID-19) Ab [Presence] in Serum or Plasma by Immunoassay
    95542-7SARS-CoV-2 (COVID-19) Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
    94769-7SARS-CoV-2 (COVID-19) Ab [Units/volume] in Serum or Plasma by Immunoassay
    96118-5SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay
    94504-8SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay
    94503-0SARS-CoV-2 (COVID-19) Ab panel - Serum, Plasma or Blood by Rapid immunoassay
    94558-4SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory specimen by Rapid immunoassay
    96119-3SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
    97097-0SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
    96094-8SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection
    98080-5SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Saliva (oral fluid) by NAA with probe detection
    96896-6SARS-CoV-2 (COVID-19) clade [Type] in Specimen by Molecular genetics method
    96764-6SARS-CoV-2 (COVID-19) E gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
    96763-8SARS-CoV-2 (COVID-19) E gene [Presence] in Respiratory specimen by NAA with probe detection
    94562-6SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
    94768-9SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
    95427-1SARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence
    94720-0SARS-CoV-2 (COVID-19) IgA Ab [Units/volume] in Serum or Plasma by Immunoassay
    95125-1SARS-CoV-2 (COVID-19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay
    96742-2SARS-CoV-2 (COVID-19) IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay
    94761-4SARS-CoV-2 (COVID-19) IgG Ab [Presence] in DBS by Immunoassay
    94563-4SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
    94507-1SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
    95429-7SARS-CoV-2 (COVID-19) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
    94505-5SARS-CoV-2 (COVID-19) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
    94547-7SARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay
    95416-4SARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay
    94564-2SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum or Plasma by Immunoassay
    94508-9SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
    95428-9SARS-CoV-2 (COVID-19) IgM Ab [Titer] in Serum or Plasma by Immunofluorescence
    94506-3SARS-CoV-2 (COVID-19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
    96895-8SARS-CoV-2 (COVID-19) lineage [Identifier] in Specimen by Molecular genetics method
    100157-7SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing
    96957-6SARS-CoV-2 (COVID-19) M gene [Presence] in Upper respiratory specimen by NAA with probe detection
    95521-1SARS-CoV-2 (COVID-19) N gene [#/volume] (viral load) in Respiratory specimen by NAA with probe detection
    96898-2SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection
    94510-5SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by NAA with probe detection
    94311-8SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N1
    94312-6SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N2
    95522-9SARS-CoV-2 (COVID-19) N gene [Log #/volume] (viral load) in Respiratory specimen by NAA with probe detection
    94760-6SARS-CoV-2 (COVID-19) N gene [Presence] in Nasopharynx by NAA with probe detection
    96986-5SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with non-probe detection
    95409-9SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with probe detection
    94533-7SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory specimen by NAA with probe detection
    94756-4SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N1
    94757-2SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N2
    95425-5SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection
    96448-6SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N1
    96958-4SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N2
    94766-3SARS-CoV-2 (COVID-19) N gene [Presence] in Serum or Plasma by NAA with probe detection
    94316-7SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by NAA with probe detection
    94307-6SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N1
    94308-4SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N2
    99596-9SARS-CoV-2 (COVID-19) N protein IgG Ab [Presence] in Serum or Plasma by Immunoassay
    95411-5SARS-CoV-2 (COVID-19) neutralizing antibody [Presence] in Serum by pVNT
    95410-7SARS-CoV-2 (COVID-19) neutralizing antibody [Titer] in Serum by pVNT
    97098-8SARS-CoV-2 (COVID-19) Nsp2 gene [Presence] in Upper respiratory specimen by NAA with probe detection
    98132-4SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Respiratory specimen by NAA with probe detection
    98494-8SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Saliva (oral fluid) by NAA with probe detection
    96899-0SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection
    94644-2SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
    94511-3SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Specimen by NAA with probe detection
    94559-2SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Respiratory specimen by NAA with probe detection
    95824-9SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection
    94639-2SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Specimen by NAA with probe detection
    97104-4SARS-CoV-2 (COVID-19) ORF1ab region [Units/volume] (viral load) in Upper respiratory specimen by NAA with probe detection
    98131-6SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Respiratory specimen by NAA with probe detection
    98493-0SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Saliva (oral fluid) by NAA with probe detection
    94646-7SARS-CoV-2 (COVID-19) RdRp gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
    94645-9SARS-CoV-2 (COVID-19) RdRp gene [Cycle Threshold #] in Specimen by NAA with probe detection
    96120-1SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Lower respiratory specimen by NAA with probe detection
    94534-5SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Respiratory specimen by NAA with probe detection
    96091-4SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection
    94314-2SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Specimen by NAA with probe detection
    96123-5SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Upper respiratory specimen by NAA with probe detection
    99314-7SARS-CoV-2 (COVID-19) RdRp gene mutation detected [Identifier] in Specimen by Molecular genetics method
    94745-7SARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
    94746-5SARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Specimen by NAA with probe detection
    94819-0SARS-CoV-2 (COVID-19) RNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
    94565-9SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with non-probe detection
    94759-8SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
    95406-5SARS-CoV-2 (COVID-19) RNA [Presence] in Nose by NAA with probe detection
    96797-6SARS-CoV-2 (COVID-19) RNA [Presence] in Oropharyngeal wash by NAA with probe detection
    95608-6SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with non-probe detection
    94500-6SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with probe detection
    95424-8SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by Sequencing
    94845-5SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
    94822-4SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by Sequencing
    94660-8SARS-CoV-2 (COVID-19) RNA [Presence] in Serum or Plasma by NAA with probe detection
    94309-2SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by NAA with probe detection
    96829-7SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen from Donor by NAA with probe detection
    96897-4SARS-CoV-2 (COVID-19) RNA panel - Oropharyngeal wash by NAA with probe detection
    94531-1SARS-CoV-2 (COVID-19) RNA panel - Respiratory specimen by NAA with probe detection
    95826-4SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection
    94306-8SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection
    96900-6SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection
    94642-6SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
    94643-4SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Specimen by NAA with probe detection
    94640-0SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory specimen by NAA with probe detection
    95609-4SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory specimen by Sequencing
    96765-3SARS-CoV-2 (COVID-19) S gene [Presence] in Saliva (oral fluid) by NAA with probe detection
    94767-1SARS-CoV-2 (COVID-19) S gene [Presence] in Serum or Plasma by NAA with probe detection
    94641-8SARS-CoV-2 (COVID-19) S gene [Presence] in Specimen by NAA with probe detection
    96752-1SARS-CoV-2 (COVID-19) S gene mutation [Presence] in Specimen by Molecular genetics method
    96751-3SARS-CoV-2 (COVID-19) S gene mutation detected [Identifier] in Specimen by Molecular genetics method
    99597-7SARS-CoV-2 (COVID-19) S protein IgG Ab [Presence] in Serum or Plasma by Immunoassay
    96603-6SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Presence] in Serum or Plasma by sVNT
    98732-1SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Titer] in Serum or Plasma by Immunoassay
    98734-7SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Units/volume] in Serum or Plasma by Immunoassay
    96894-1SARS-CoV-2 (COVID-19) sequencing and identification panel - Specimen by Molecular genetics method
    95970-0SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements [Presence] in Blood by Sequencing
    100156-9SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection
    96741-4SARS-CoV-2 (COVID-19) variant [Type] in Specimen by Sequencing
    96755-4SARS-CoV-2 (COVID-19) variant interpretation in Specimen Narrative
    94764-8SARS-CoV-2 (COVID-19) whole genome [Nucleotide sequence] in Isolate or Specimen by Sequencing
    99772-6SARS-CoV-2 stimulated gamma interferon [Interpretation] in Blood Qualitative
    95971-8SARS-CoV-2 stimulated gamma interferon [Presence] in Blood
    95974-2SARS-CoV-2 stimulated gamma interferon panel - Blood
    95972-6SARS-CoV-2 stimulated gamma interferon release by T-cells [Units/volume] corrected for background in Blood
    95973-4SARS-CoV-2 stimulated gamma interferon release by T-cells [Units/volume] in Blood
    94509-7SARS-related coronavirus E gene [Cycle Threshold #] in Specimen by NAA with probe detection
    96121-9SARS-related coronavirus E gene [Presence] in Lower respiratory specimen by NAA with probe detection
    94758-0SARS-related coronavirus E gene [Presence] in Respiratory specimen by NAA with probe detection
    95823-1SARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection
    94765-5SARS-related coronavirus E gene [Presence] in Serum or Plasma by NAA with probe detection
    94315-9SARS-related coronavirus E gene [Presence] in Specimen by NAA with probe detection
    96122-7SARS-related coronavirus E gene [Presence] in Upper respiratory specimen by NAA with probe detection
    94313-4SARS-related coronavirus N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N3
    94310-0SARS-related coronavirus N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N3
    94502-2SARS-related coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection
    94647-5SARS-related coronavirus RNA [Presence] in Specimen by NAA with probe detection
    94532-9SARS-related coronavirus+MERS coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection
    98062-3Sequencing study identifier
    100342-5Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry

 

Expansion

Generated Narrative: ValueSet

Expansion based on Loinc v1.0.1

This value set contains 159 concepts

CodeSystemDisplay
  100861-4http://loinc.orgCells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
  100858-0http://loinc.orgCells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
  100862-2http://loinc.orgCells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
  100859-8http://loinc.orgCells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
  100863-0http://loinc.orgCells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
  100860-6http://loinc.orgCells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
  96766-1http://loinc.orgGISAID sequence accession number
  95942-9http://loinc.orgInfluenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay
  97099-6http://loinc.orgInfluenza virus A and B and SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay
  95941-1http://loinc.orgInfluenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory specimen by NAA with probe detection
  95380-2http://loinc.orgInfluenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection
  95423-0http://loinc.orgInfluenza virus A and B and SARS-CoV-2 (COVID-19) identified in Respiratory specimen by NAA with probe detection
  95422-2http://loinc.orgInfluenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Respiratory specimen by NAA with probe detection
  100345-8http://loinc.orgInfluenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection
  98733-9http://loinc.orgPercent neutralization by SARS coronavirus 2 spike protein RBD neutralizing antibody in Serum or Plasma by Immunoassay
  99771-8http://loinc.orgSARS coronavirus 2 spike and nucleocapsid protein stimulated gamma interferon panel - Blood
  98846-9http://loinc.orgSARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells [Units/volume] corrected for background in Blood by Immunoassay
  98847-7http://loinc.orgSARS coronavirus 2 stimulated gamma interferon release by lymphocytes [Units/volume] corrected for background in Blood by Immunoassay
  99774-2http://loinc.orgSARS coronavirus 2 stimulated gamma interferon release by T-cells.Nucleocapsid Ag spot count [#] corrected for background in Blood
  99773-4http://loinc.orgSARS coronavirus 2 stimulated gamma interferon release by T-cells.Spike Ag spot count [#] corrected for background in Blood
  95209-3http://loinc.orgSARS-CoV+SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory specimen by Rapid immunoassay
  94763-0http://loinc.orgSARS-CoV-2 (COVID-19) [Presence] in Specimen by Organism specific culture
  94661-6http://loinc.orgSARS-CoV-2 (COVID-19) Ab [Interpretation] in Serum or Plasma
  95825-6http://loinc.orgSARS-CoV-2 (COVID-19) Ab [Presence] in DBS by Immunoassay
  98069-8http://loinc.orgSARS-CoV-2 (COVID-19) Ab [Presence] in Saliva (oral fluid) by Rapid immunoassay
  94762-2http://loinc.orgSARS-CoV-2 (COVID-19) Ab [Presence] in Serum or Plasma by Immunoassay
  95542-7http://loinc.orgSARS-CoV-2 (COVID-19) Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
  94769-7http://loinc.orgSARS-CoV-2 (COVID-19) Ab [Units/volume] in Serum or Plasma by Immunoassay
  96118-5http://loinc.orgSARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay
  94504-8http://loinc.orgSARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay
  94503-0http://loinc.orgSARS-CoV-2 (COVID-19) Ab panel - Serum, Plasma or Blood by Rapid immunoassay
  94558-4http://loinc.orgSARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory specimen by Rapid immunoassay
  96119-3http://loinc.orgSARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
  97097-0http://loinc.orgSARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
  96094-8http://loinc.orgSARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection
  98080-5http://loinc.orgSARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Saliva (oral fluid) by NAA with probe detection
  96896-6http://loinc.orgSARS-CoV-2 (COVID-19) clade [Type] in Specimen by Molecular genetics method
  96764-6http://loinc.orgSARS-CoV-2 (COVID-19) E gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
  96763-8http://loinc.orgSARS-CoV-2 (COVID-19) E gene [Presence] in Respiratory specimen by NAA with probe detection
  94562-6http://loinc.orgSARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
  94768-9http://loinc.orgSARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
  95427-1http://loinc.orgSARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence
  94720-0http://loinc.orgSARS-CoV-2 (COVID-19) IgA Ab [Units/volume] in Serum or Plasma by Immunoassay
  95125-1http://loinc.orgSARS-CoV-2 (COVID-19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay
  96742-2http://loinc.orgSARS-CoV-2 (COVID-19) IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay
  94761-4http://loinc.orgSARS-CoV-2 (COVID-19) IgG Ab [Presence] in DBS by Immunoassay
  94563-4http://loinc.orgSARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
  94507-1http://loinc.orgSARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
  95429-7http://loinc.orgSARS-CoV-2 (COVID-19) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
  94505-5http://loinc.orgSARS-CoV-2 (COVID-19) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
  94547-7http://loinc.orgSARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay
  95416-4http://loinc.orgSARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay
  94564-2http://loinc.orgSARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum or Plasma by Immunoassay
  94508-9http://loinc.orgSARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
  95428-9http://loinc.orgSARS-CoV-2 (COVID-19) IgM Ab [Titer] in Serum or Plasma by Immunofluorescence
  94506-3http://loinc.orgSARS-CoV-2 (COVID-19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
  96895-8http://loinc.orgSARS-CoV-2 (COVID-19) lineage [Identifier] in Specimen by Molecular genetics method
  100157-7http://loinc.orgSARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing
  96957-6http://loinc.orgSARS-CoV-2 (COVID-19) M gene [Presence] in Upper respiratory specimen by NAA with probe detection
  95521-1http://loinc.orgSARS-CoV-2 (COVID-19) N gene [#/volume] (viral load) in Respiratory specimen by NAA with probe detection
  96898-2http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection
  94510-5http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by NAA with probe detection
  94311-8http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N1
  94312-6http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N2
  95522-9http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Log #/volume] (viral load) in Respiratory specimen by NAA with probe detection
  94760-6http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Nasopharynx by NAA with probe detection
  96986-5http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with non-probe detection
  95409-9http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with probe detection
  94533-7http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory specimen by NAA with probe detection
  94756-4http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N1
  94757-2http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N2
  95425-5http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection
  96448-6http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N1
  96958-4http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N2
  94766-3http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Serum or Plasma by NAA with probe detection
  94316-7http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by NAA with probe detection
  94307-6http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N1
  94308-4http://loinc.orgSARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N2
  99596-9http://loinc.orgSARS-CoV-2 (COVID-19) N protein IgG Ab [Presence] in Serum or Plasma by Immunoassay
  95411-5http://loinc.orgSARS-CoV-2 (COVID-19) neutralizing antibody [Presence] in Serum by pVNT
  95410-7http://loinc.orgSARS-CoV-2 (COVID-19) neutralizing antibody [Titer] in Serum by pVNT
  97098-8http://loinc.orgSARS-CoV-2 (COVID-19) Nsp2 gene [Presence] in Upper respiratory specimen by NAA with probe detection
  98132-4http://loinc.orgSARS-CoV-2 (COVID-19) ORF1a region [Presence] in Respiratory specimen by NAA with probe detection
  98494-8http://loinc.orgSARS-CoV-2 (COVID-19) ORF1a region [Presence] in Saliva (oral fluid) by NAA with probe detection
  96899-0http://loinc.orgSARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection
  94644-2http://loinc.orgSARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
  94511-3http://loinc.orgSARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Specimen by NAA with probe detection
  94559-2http://loinc.orgSARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Respiratory specimen by NAA with probe detection
  95824-9http://loinc.orgSARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection
  94639-2http://loinc.orgSARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Specimen by NAA with probe detection
  97104-4http://loinc.orgSARS-CoV-2 (COVID-19) ORF1ab region [Units/volume] (viral load) in Upper respiratory specimen by NAA with probe detection
  98131-6http://loinc.orgSARS-CoV-2 (COVID-19) ORF1b region [Presence] in Respiratory specimen by NAA with probe detection
  98493-0http://loinc.orgSARS-CoV-2 (COVID-19) ORF1b region [Presence] in Saliva (oral fluid) by NAA with probe detection
  94646-7http://loinc.orgSARS-CoV-2 (COVID-19) RdRp gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
  94645-9http://loinc.orgSARS-CoV-2 (COVID-19) RdRp gene [Cycle Threshold #] in Specimen by NAA with probe detection
  96120-1http://loinc.orgSARS-CoV-2 (COVID-19) RdRp gene [Presence] in Lower respiratory specimen by NAA with probe detection
  94534-5http://loinc.orgSARS-CoV-2 (COVID-19) RdRp gene [Presence] in Respiratory specimen by NAA with probe detection
  96091-4http://loinc.orgSARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection
  94314-2http://loinc.orgSARS-CoV-2 (COVID-19) RdRp gene [Presence] in Specimen by NAA with probe detection
  96123-5http://loinc.orgSARS-CoV-2 (COVID-19) RdRp gene [Presence] in Upper respiratory specimen by NAA with probe detection
  99314-7http://loinc.orgSARS-CoV-2 (COVID-19) RdRp gene mutation detected [Identifier] in Specimen by Molecular genetics method
  94745-7http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
  94746-5http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Specimen by NAA with probe detection
  94819-0http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
  94565-9http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with non-probe detection
  94759-8http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
  95406-5http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Nose by NAA with probe detection
  96797-6http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Oropharyngeal wash by NAA with probe detection
  95608-6http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with non-probe detection
  94500-6http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with probe detection
  95424-8http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by Sequencing
  94845-5http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
  94822-4http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by Sequencing
  94660-8http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Serum or Plasma by NAA with probe detection
  94309-2http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by NAA with probe detection
  96829-7http://loinc.orgSARS-CoV-2 (COVID-19) RNA [Presence] in Specimen from Donor by NAA with probe detection
  96897-4http://loinc.orgSARS-CoV-2 (COVID-19) RNA panel - Oropharyngeal wash by NAA with probe detection
  94531-1http://loinc.orgSARS-CoV-2 (COVID-19) RNA panel - Respiratory specimen by NAA with probe detection
  95826-4http://loinc.orgSARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection
  94306-8http://loinc.orgSARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection
  96900-6http://loinc.orgSARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection
  94642-6http://loinc.orgSARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
  94643-4http://loinc.orgSARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Specimen by NAA with probe detection
  94640-0http://loinc.orgSARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory specimen by NAA with probe detection
  95609-4http://loinc.orgSARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory specimen by Sequencing
  96765-3http://loinc.orgSARS-CoV-2 (COVID-19) S gene [Presence] in Saliva (oral fluid) by NAA with probe detection
  94767-1http://loinc.orgSARS-CoV-2 (COVID-19) S gene [Presence] in Serum or Plasma by NAA with probe detection
  94641-8http://loinc.orgSARS-CoV-2 (COVID-19) S gene [Presence] in Specimen by NAA with probe detection
  96752-1http://loinc.orgSARS-CoV-2 (COVID-19) S gene mutation [Presence] in Specimen by Molecular genetics method
  96751-3http://loinc.orgSARS-CoV-2 (COVID-19) S gene mutation detected [Identifier] in Specimen by Molecular genetics method
  99597-7http://loinc.orgSARS-CoV-2 (COVID-19) S protein IgG Ab [Presence] in Serum or Plasma by Immunoassay
  96603-6http://loinc.orgSARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Presence] in Serum or Plasma by sVNT
  98732-1http://loinc.orgSARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Titer] in Serum or Plasma by Immunoassay
  98734-7http://loinc.orgSARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Units/volume] in Serum or Plasma by Immunoassay
  96894-1http://loinc.orgSARS-CoV-2 (COVID-19) sequencing and identification panel - Specimen by Molecular genetics method
  95970-0http://loinc.orgSARS-CoV-2 (COVID-19) specific TCRB gene rearrangements [Presence] in Blood by Sequencing
  100156-9http://loinc.orgSARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection
  96741-4http://loinc.orgSARS-CoV-2 (COVID-19) variant [Type] in Specimen by Sequencing
  96755-4http://loinc.orgSARS-CoV-2 (COVID-19) variant interpretation in Specimen Narrative
  94764-8http://loinc.orgSARS-CoV-2 (COVID-19) whole genome [Nucleotide sequence] in Isolate or Specimen by Sequencing
  99772-6http://loinc.orgSARS-CoV-2 stimulated gamma interferon [Interpretation] in Blood Qualitative
  95971-8http://loinc.orgSARS-CoV-2 stimulated gamma interferon [Presence] in Blood
  95974-2http://loinc.orgSARS-CoV-2 stimulated gamma interferon panel - Blood
  95972-6http://loinc.orgSARS-CoV-2 stimulated gamma interferon release by T-cells [Units/volume] corrected for background in Blood
  95973-4http://loinc.orgSARS-CoV-2 stimulated gamma interferon release by T-cells [Units/volume] in Blood
  94509-7http://loinc.orgSARS-related coronavirus E gene [Cycle Threshold #] in Specimen by NAA with probe detection
  96121-9http://loinc.orgSARS-related coronavirus E gene [Presence] in Lower respiratory specimen by NAA with probe detection
  94758-0http://loinc.orgSARS-related coronavirus E gene [Presence] in Respiratory specimen by NAA with probe detection
  95823-1http://loinc.orgSARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection
  94765-5http://loinc.orgSARS-related coronavirus E gene [Presence] in Serum or Plasma by NAA with probe detection
  94315-9http://loinc.orgSARS-related coronavirus E gene [Presence] in Specimen by NAA with probe detection
  96122-7http://loinc.orgSARS-related coronavirus E gene [Presence] in Upper respiratory specimen by NAA with probe detection
  94313-4http://loinc.orgSARS-related coronavirus N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N3
  94310-0http://loinc.orgSARS-related coronavirus N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N3
  94502-2http://loinc.orgSARS-related coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection
  94647-5http://loinc.orgSARS-related coronavirus RNA [Presence] in Specimen by NAA with probe detection
  94532-9http://loinc.orgSARS-related coronavirus+MERS coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection
  98062-3http://loinc.orgSequencing study identifier
  100342-5http://loinc.orgVolatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code